Good afternoon :)
Switch to
Place Order

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹298 cr, stock is ranked 1,396
High RiskStock is 3.58x as volatile as Nifty
121.500.65 (+0.54%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹298 cr, stock is ranked 1,396
High RiskStock is 3.58x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-15.42
PB RatioPB Ratio
3.77
Dividend YieldDiv. Yield
Sector PESector PE
38.48
Sector PBSector PB
5.13
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

201820192020202155.9557.9170.1077.99-13.82-14.80-24.37-19.36
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnOct 8, 2021

Brooks Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 07, 2021. | Download

Brooks Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 07, 2021. | Download

Reply to Clarification Sought 
Announced OnOct 4, 2021

BROOKS: The Exchange had sought clarification from Brooks Laboratories Limited with respect to announcement dated 29-Sep-2021, regardingᅡᅠ Appointment of Mrs Kaushalya Singh as Executive Director of the company w.e.f. September 29, 2021. On basis of above the Company was required to clarify following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The response of the Company is attached. | Download

BROOKS: The Exchange had sought clarification from Brooks Laboratories Limited with respect to announcement dated 29-Sep-2021, regardingᅡᅠ Appointment of Mrs Kaushalya Singh as Executive Director of the company w.e.f. September 29, 2021. On basis of above the Company was required to clarify following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The response of the Company is attached. | Download

Updates 
Announced OnSep 30, 2021

Brooks Laboratories Limited has informed the Exchange regarding 'Voting Results alongwith Scrutinizers report for the 19th AGM of the Company held on 29.09.2021'. | Download

Brooks Laboratories Limited has informed the Exchange regarding 'Voting Results alongwith Scrutinizers report for the 19th AGM of the Company held on 29.09.2021'. | Download

See all events